tradingkey.logo
tradingkey.logo
Search

Stryker Corp

SYK
Add to Watchlist
338.610USD
+1.180+0.35%
Close 08-07 16:00ETQuotes delayed by 15 min
130.04BMarket Cap
38.81P/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

+0.35%

5 Days

+3.96%

1 Month

+2.69%

6 Months

-5.49%

Year to Date

-3.66%

1 Year

-10.03%

Key Figures
336.690Open
340.000High
1.85MVolume
38.81P/E TTM
20.02P/E Dynamic
3.440Dividend TTM
0.48%Turnover Ratio
337.430Prev. Close
332.540Low
283.60MTurnover
43.27P/E Static
5.40P/B
1.02%Div Yield TTM
7.23%ROA
404.87052wk High
0.65Volume Ratio
2.99BNet Profit
382.50MShares
8.7252EPS TTM
0.79Beta
15.20%ROE
281.00052wk Low
2.21%Amplitude
65.78%Gross Margin
130.04BMarket Cap
1.65Reward/Risk
1.41%Risk Rate

Stryker Corp Stock (SYK) Moved Up by 4.41% on Aug 3: What Investors Need To Know

• Stryker exceeded second-quarter earnings expectations across MedSurg and Neurotechnology segments. • Management raised full-year earnings guidance citing operational efficiencies and market share gains. • Analysts maintain a Buy rating with an average price target of $385.60.

TradingKeyMon, Aug 3

Stryker Corp Stock (SYK) Moved Down by 6.58% on Jul 31: What Investors Need To Know

• Stryker's stock declined following an earnings miss and contraction in operating margins. • Management lowered forward-looking guidance due to inflationary pressures and cooling elective procedure demand. • Analysts reduced price targets as automated selling programs accelerated downward stock momentum.

TradingKeyFri, Jul 31

Stryker Corp Stock (SYK) Moved Up by 3.15% on Jul 24: Facts Behind the Movement

• Stryker exceeded second-quarter earnings expectations driven by strong MedSurg and Neurotechnology segment performance. • Management raised full-year organic growth and earnings guidance following higher elective procedure volumes. • Analyst upgrades and increased institutional demand contributed to positive momentum in Stryker shares.

TradingKeyFri, Jul 24

Stryker Corp Stock (SYK) Closed Up by 3.21% on Jul 23: Drivers Behind the Movement

• Stryker’s second-quarter earnings exceeded analyst expectations with growth in MedSurg and Neurotechnology. • Management raised full-year earnings guidance citing strong demand and elective procedure recovery. • Analysts increased price targets following positive performance and consistent robotic technology market expansion.

TradingKeyThu, Jul 23

Stryker Corp Stock (SYK) Moved Down by 3.42% on Jul 17: A Full Analysis

• Stryker stock fell due to concerns regarding orthopedic demand and hospital capital spending. • Elevated treasury yields are compressing valuation multiples for high-growth medical technology firms. • Technical breaches of support levels and institutional profit-taking contributed to intraday price volatility.

TradingKeyFri, Jul 17

Stryker Corp Stock (SYK) Moved Down by 5.49% on Jul 14: A Full Analysis

• Stryker shares declined due to concerns over decelerating hospital capital equipment spending. • Increased competition in the orthopedic market threatens Stryker’s premium pricing power and margins. • Macroeconomic factors, including labor inflation and foreign exchange, are pressuring company earnings.

TradingKeyTue, Jul 14

Stryker Corp's Score

0.00vs previous score
Forecast8.47
Financial Health8.31
Technical3.55
Valuation Dimensions9.35
Institutional Confidence7.00
Risk Assessment9.56

Media Coverage

Coverage Level

43°C

Very Low
Very High
Positive

Analyst Rating

Strong Buy
Buy
Hold
Sell
Strong Sell
BuyCurrent Rating
383.365Target Price
+14.11%Upside Space
Current Rating2026-082026-072026-062026-052026-042026-032026-022026-01
Strong Buy1212121111101010
Buy1312131314141413
Hold56888889
Sell00000000
Strong Sell00000000

Stryker Corp Technical Analysis

1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D

Technical Indicators

Buy

Summary

Buy

Moving Average

Buy

Financial Indicators

Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Earnings

Next reporting date
2026-07-30
Reporting Period
2026Q2
Earnings / Forecast
3.33/3.49
Revenue / Forecast
6.59B/6.58B

Stryker Corp Profile

SectorHealthcare Equipment & Supplies
Ticker SymbolSYK
Number of employees53000
CountryUnited States of America

Ownership

ShareholdersProportion
Vanguard Capital Management, LLC5.84%
Brown (John W)5.23%
BlackRock Institutional Trust Company, N.A.4.39%
Greenleaf Trust4.16%
Shareholder TypesProportion
Investment Advisor45.13%
Investment Advisor/Hedge Fund21.50%
Bank and Trust6.47%
Individual Investor5.39%

FAQs

What is the current price of Stryker Corp (SYK)?

The current price of Stryker Corp (SYK) is 338.61.

What is the symbol of Stryker Corp?

The ticker symbol of Stryker Corp is SYK.

What is the 52-week high of Stryker Corp?

The 52-week high of Stryker Corp is 404.87.

What is the 52-week low of Stryker Corp?

The 52-week low of Stryker Corp is 281.00.

What is the market capitalization of Stryker Corp?

The market capitalization of Stryker Corp is 129.52B.

Is Stryker Corp (SYK) currently rated as Buy, Hold, or Sell?

According to analysts, Stryker Corp (SYK) has an overall rating of Buy, with a price target of 383.36.

What is the Earnings Per Share (EPS TTM) of Stryker Corp (SYK)?

The Earnings Per Share (EPS TTM) of Stryker Corp (SYK) is 8.49.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.